Constable, Ian J.,Rakoczy, P. Elizabeth,Lai, Chooi-may,Chalberg Jr., Thomas W.
申请号:
AU2013263159
公开号:
AU2013263159B2
申请日:
2013.05.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase- 1 (sFlt-1) protein to the human subject.